ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.14
+0.18 (3.63%)
At close: Apr 15, 2026, 4:00 PM EDT
5.00
-0.14 (-2.72%)
After-hours: Apr 15, 2026, 4:58 PM EDT
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $6.38 million as of April 15, 2026. Its market cap has increased by 193.29% in one year.
Market Cap
6.38M
Enterprise Value
6.11M
1-Year Change
193.29%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.15M to $6.38M, a decrease of -57.91%. That is a compound annual growth rate of -9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 6.15M | 16.47% |
| Dec 31, 2025 | 5.28M | 57.21% |
| Dec 31, 2024 | 3.36M | -81.25% |
| Dec 29, 2023 | 17.92M | 39.49% |
| Dec 30, 2022 | 12.85M | -55.92% |
| Dec 31, 2021 | 29.15M | 15.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MDxHealth | 109.92M |
| Insight Molecular Diagnostics | 96.50M |
| Exagen | 71.44M |
| Precipio | 50.03M |
| bioAffinity Technologies | 14.29M |
| Check-Cap | 13.12M |
| XWELL | 9.35M |
| Advanced Biomed | 8.94M |